Profound Hyperthermia After Postpartum Rectal Misoprostol Administration

Obstet Gynecol. 2016 Jun;127(6):1067-1069. doi: 10.1097/AOG.0000000000001394.

Abstract

Background: Misoprostol, a synthetic prostaglandin E1 analog, is commonly used for treatment and prevention of postpartum hemorrhage. Known side effects include transient hyperthermia, chills, nausea, vomiting, and diarrhea.

Case: After a precipitous vaginal delivery complicated by postpartum hemorrhage (600-mL blood loss), a healthy 21-year-old multiparous patient received 800 micrograms rectal misoprostol. Within 30 minutes, she developed rigors, severe hyperthermia (41.5°C [106.7°F]), tachycardia (170s), and transient encephalopathy. Antibiotics and a cooling protocol were initiated in the intensive care unit. Her abnormal vital signs resolved 7-8 hours later. Extensive workup was negative.

Conclusion: It is important to consider misoprostol toxicity in postpartum hyperthermia, rigors, and tachycardia. Misoprostol should be used judiciously given a lack of evidence for its effectiveness and its potential for serious side effects.

Publication types

  • Case Reports

MeSH terms

  • Administration, Rectal
  • Diagnosis, Differential
  • Female
  • Fever / diagnosis*
  • Fever / etiology
  • Humans
  • Misoprostol / administration & dosage
  • Misoprostol / adverse effects
  • Misoprostol / therapeutic use*
  • Oxytocics / administration & dosage
  • Oxytocics / adverse effects
  • Oxytocics / therapeutic use*
  • Postpartum Hemorrhage / prevention & control*
  • Pregnancy
  • Young Adult

Substances

  • Oxytocics
  • Misoprostol